PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Yıldırım, S. ; Mhamane, A. ; Lösch, S. ; Wieder, A. ; Ermis, E. ; König, A.-C. ; Yilmaz, S. ; Hauck, S.M. ; Kocabaş, F.* ; Szendroedi, J. ; Herzig, S. ; Ekim Üstünel, B.

TSC22D1 is a newly identified inhibitor of insulin secretion in pancreatic beta cells.

FEBS J., DOI: 10.1111/febs.70194 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The loss of pancreatic beta cell function leads to chronically high blood glucose levels, contributing to diabetes mellitus, one of the leading causes of morbidity and mortality worldwide. Understanding the molecular mechanisms that regulate beta cell function could pave the way for the development of more effective antidiabetic treatments. In this study, we identify the evolutionarily conserved transforming growth factor β-1 stimulated clone D1 (TSC22D1) protein as a previously unknown regulator of beta cell function. TSC22D1 depletion in INS-1E cells enhances the expression of key beta cell identity genes, including Ins1, Ins2, Pdx1, Slc2a2, and Nkx6.1, and promotes glucose-stimulated insulin secretion without altering intracellular insulin content. Mechanistically, TSC22D1 and Forkhead box protein O1 (FoxO1) interact and regulate each other in a reciprocal manner to control beta cell function. Our follow-up interactome and RNA-Seq analyses reveal that TSC22D1 is crucial for glucose-responsive cellular processes in beta cells, including mRNA processing, ribonucleoprotein complex biogenesis, and Golgi vesicle transport. Overall, our findings indicate that TSC22D1 plays a significant role in regulating beta cell function at multiple levels, with potential implications for metabolic diseases, such as diabetes.
Impact Factor
Scopus SNIP
Altmetric
4.200
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Foxo1 ; Tsc22d1 ; Pancreatic Beta Cells And Insulin Secretion; Stimulated Clone-22; Tsc-22; Growth; Expression; Apoptosis; Foxo1; Differentiation; Secretagogin; Proteins; Proteome
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1742-464X
e-ISSN 1742-4658
Zeitschrift FEBS Journal, The
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
CF Metabolomics & Proteomics (CF-MPC)
POF Topic(s) 90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-501900-251
G-505700-001
Förderungen Scientific and Technological Research Council of Turkey (TUBITAK)
DOI 10.1111/febs.70194
WOS ID 001530997200001
Scopus ID 105011155919
PubMed ID 40679946
Erfassungsdatum 2025-07-22
[➜Korrektur melden]